These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2438669)

  • 1. [Anti-keratin antibodies: their significance in the diagnosis and prognosis of systemic connective tissue diseases].
    Małdyk E
    Pol Tyg Lek; 1987 Jan; 42(2):35-7. PubMed ID: 2438669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diversity of systemic connective tissue disorders].
    Julkunen H; Ekblom-Kullberg S
    Duodecim; 2004; 120(15):1876-83. PubMed ID: 15508761
    [No Abstract]   [Full Text] [Related]  

  • 3. Connective tissue diseases: advances in diagnosis and management.
    Vyse TJ; Walport MJ
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):121-32. PubMed ID: 8353664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunology of systemic connective tissue diseases].
    Hána I; Dostál C; Bardfeld R
    Cas Lek Cesk; 1984 Sep; 123(38-39):1178-81. PubMed ID: 6498919
    [No Abstract]   [Full Text] [Related]  

  • 5. [How can the autoantibody detection help in the diagnostics and evaluation of autoimmune rheumatic diseases?].
    Vencovský J
    Vnitr Lek; 2006; 52(7-8):697-701. PubMed ID: 16967611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.
    Wiik AS
    Scand J Rheumatol; 2005; 34(4):260-8. PubMed ID: 16195158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New chronic inflammatory diseases of connective tissue].
    Meurer M
    Hautarzt; 1985; 36 Suppl 7():122-4. PubMed ID: 3879875
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of antihistone and anti-bicatenary RNA antibodies in connective tissue diseases using immunoenzyme technic].
    Gioud M; Ait Kaci A; Sepetjan M; Monier JC
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):385-91. PubMed ID: 7100807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
    Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
    Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial antigenicity in diffuse connective tissue diseases].
    de Mendonça LL; Yoshinari NH; Balthazar PA; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):293-7. PubMed ID: 8029603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-keratin antibodies in human sera: naturally occurring or induced?
    Ablin RJ
    J Invest Dermatol; 1987 Oct; 89(4):435-6. PubMed ID: 2444654
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of autoantibodies in clinical practice].
    Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
    Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interstitial lung disease in patients with connective tissue diseases].
    Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic tests for connective tissue diseases and the primary vasculitides.
    Warner NB
    Dermatol Clin; 1994 Jan; 12(1):161-73. PubMed ID: 8143379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of some immunoserologic diagnostic tests in systemic diseases.
    Rozman B; Kveder T; Lestan B
    Acta Med Austriaca; 1988; 15(5):148-9. PubMed ID: 3265251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.